Breviscapine promotes K562 cell apoptosis induced by doxorubicin

Chinese Pharmacological Bulletin

Volumn 23, Issue 8, 2007, Pages 1043-1047

  Du, Gang Jun ^a   Lin, Hai Hong ^a   Xu, Qi Tai ^a  

^a HENAN UNIVERSITY   (China)

Author keywords

Apoptosis; Breviscapine; Doxorubicin; K562; Lymphocyte

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BREVISCAPINE; CASPASE 3; CASPASE 8; CYTOCHROME C; DNA; DOXORUBICIN; HISTONE; PROTEIN BNIP3; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; COLORIMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 35148838128     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Papazisis K T, Kalemi T G, Zambouli D, et al. Synergistic effects of protein tyrosine kinase inhibitor genistein with camptothecins against three cell lines in vitro[J]. Cancer Lett,2006,233(2):255-64.
2. He W, Zeng F D. Protective efects of breviscapine on myocardial hypertrophyand fibrosis induced by isoproterenol in rats[J]. Chin Pharmacol Bull,2005,21(12):1514-7.
3. Ali Abdella, Gan L, Liu Q, et al. Antioxidant effect of scutellarin and its antagonistic action on the liver toxicity of Se in rats[J]. Chin Pharmacol Bull,2003,19(1):113-5.
4. Wu Y G, Lin H, Qian H, et al. Experim ental study of effect of breviscapine on expression of transforming growth factor-β and connective tissue growth factor in kidney in diabetic rats[J]. Chin Pharmacol Bull,2004,20(9):1050-4.
5. Kawatani M, Uchi M, Simizu S, et al. Transmembrane domain of Bcl-2 is required for inhibition of ceramide synthesis, but not cytochrome c release in the pathway of inostamycin-induced apoptosis [J]. Exp Cell Res,2003,286(1):57-66.
6. Li Y, Ahmed F, Ali S, et al. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells[J]. Cancer Res,2005,65(15):6934-42.
7. Cardenas M, Marder M, Blank V C, Roguin L P. Antitumor activity of some natural flavonoids and synthetic derivatives on various human and murine cancer cell lines[J]. Bioorg Med Chem, 2006,14(9):2966-71.
8. Serova M, Ghoul A, Benhadji KA et al. Preclinical and clinical development of novel agents that target the protein kinase C family [J]. Semin Oncol,2006,33(4):466-78.
9. Michie A M, Nakagawa R. Elucidating the role of protein kinase C in chronic lymphocytic leukaemia[J]. Hematol Oncol,2006,24 (3):134-8.
10. Nakagawa R, Soh J W, Michie A M. Subversion of protein kinase C alpha signaling in hematopoietic progenitor cells results in the generation of a B-cell chronic lymphocytic leukemia-like population in vivo[J]. Cancer Res,2006,66(1):527-34.
11. Baldwin R M, Garratt-Lalonde M, Parolin D A, et al. Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Ciota-mediated attenuation of p38 MAP kinase signaling[J]. Oncogene,2006,25(20): 2909-19.
12. Zhang J, Liu N, Zhang J, et al. PKCdelta protects human breast tumor MCF-7 cells against tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis[J]. J Cell Biochem,2005,96 (3):522-32.
13. Querfeld C, Rizvi M A, Kuzel T M, et al. The selective protein kinase C beta inhibitor enzastaurin induces apoptosis in cutaneous T-cell lymphoma cell lines through the AKT pathway[J]. J Invest Dermatol,2006,126(7): 1641-7.
14. Zhu B H, Yao Z X, Luo S J, et al. Effects of antisense oligonucleotides of PKC-alpha on proliferation and apoptosis of HepG2 in vitro[J]. Hepatobiliary Pancreat Dis Int,2005,4(1):75-9.
15. Zhou H, Chen S X, Wang L X, et al. Effect of breviscapine on protein kinase C of chronic hypoxic rats[J]. Chin Pharmacol Bull, 2002,18(1):39-42.